Filtering the blood to keep cancer in check

December 16, 2015 by Majid Warkiani, Science in Public
Dr Majid Warkiani. Credit: Australian Centre for NanoMedicine, UNSW

A new diagnostic system used to detect cancer cells in small blood samples could next be turned towards filtering a patient's entire system to remove those dangerous cells – like a dialysis machine for cancer – says an Australian researcher who helped develop the system.

The technique was developed for diagnosis, and is capable of detecting (and removing) a tiny handful of cancer-spreading from amongst the billions of healthy cells in a small blood sample.

The revolutionary , which works to diagnose cancer at a tenth of the cost of competing technologies, is now in clinical trials in the US, UK, Singapore and Australia, and is in the process of being commercialised by Clearbridge BioMedics PteLtd in Singapore.

"It's like a non-invasive 'liquid biopsy' that can flag the presence of any type of solid cancer – like lung, breast, bowel, and so on – without the need for surgery," says Dr Majid Warkiani, a lecturer at the School of Mechanical and Manufacturing Engineering at the University of New South Wales, and a project leader at the Australian Centre for NanoMedicine at UNSW.

The initial challenge in developing the early-warning diagnosis system was to find those few amongst billions of healthy blood cells. That challenge was met by a system that 'spins out' and isolates circulating tumour cells (CTCs), which are shed into the bloodstream from a solid tumour and can establish tumours elsewhere in the body—the mechanism by which cancer spreads through the body.

Isolation of Circulating Tumour Cells

The 'liquid biopsy' can thus be used both for early cancer diagnosis and for monitoring a patient's response to treatment.

But the potential for the new system goes far beyond just diagnosis.

If the filtering system could be scaled up, a cancer patient's entire blood supply could potentially be similarly filtered, removing the dangerous cells and cycling the rest of the patient's blood back into their system. It would be similar to dialysis treatment for kidney patients.

"It would be a revolution in cancer treatment. You would keep filtering out the dangerous cells, prolonging the life of the patient," says Dr Warkiani. "There is still a long way to go—including securing money and support in Australia—before this is possible.'

But he believes this new technology will become one of the essential components of routine cancer management in the near future.

"A therapeutic version of this system, used for blood cleansing, could make the cancer a chronic disease and decrease drastically its mortality rate," he says.

Majid was the NSW winner of Fresh Science, a national program that helps early-career researchers find and share their stories of discovery. Fresh Science is helping to build a cadre of skilled science communicators. In 2015, Fresh Science ran in every mainland state, with 180 early-career researchers nominating for the six Fresh Science events held this year in Melbourne, Townsville, Brisbane, Perth, Adelaide and Sydney.

Over 50 early-career researchers nominated for Fresh Science NSW, which was held at the Australian Museum (training) and Three Wise Monkeys Hotel (public challenge event) and was supported by the Australian Museum and the University of New South Wales.

Explore further: New technique efficiently captures and grows tumour cells to guide selection of drug therapy

Related Stories

New technique efficiently captures and grows tumour cells to guide selection of drug therapy

December 1, 2015
Scientists from the National University of Singapore (NUS) have developed a novel technique to efficiently culture clusters containing circulating tumour cells (CTCs) in 14 days that could be used to predict the outcome of ...

DNA in blood can track cancer development and response in real time

November 4, 2015
Scientists have shown for the first time that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment, according to a new Cancer Research UK study published in ...

Blood test could match cancer patients to best treatments

October 15, 2015
UK-funded scientists have developed a blood test that could help pair cancer patients with the most suitable therapy for their disease and then track the tumour's progress to see if the treatment is working, according to ...

Trapping cells that tumors release into the bloodstream allows fast and sensitive genetic analysis

October 7, 2015
A simple and non-invasive method to detect cancer-related mutations without direct biopsy sampling of tumors has been developed by A*STAR researchers.

Imaging test detects aggressive and treatment-resistant cancers

December 10, 2015
Scientists have developed a new imaging test that could enable doctors to identify more dangerous tumours before they spread around the body - and tailor treatment accordingly.

Blood test can help some bowel cancer patients avoid unnecessary drug side-effects

March 25, 2015
Manchester researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.

Recommended for you

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Removing the enablers: Reducing number of tumor-supporting cells to fight neuroblastoma

April 24, 2018
Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune cell—can negatively ...

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

New test could tell doctors whether patients will respond to chemotherapy

April 24, 2018
Less than half the patients diagnosed with cancer respond favorably to chemotherapy, but a new method for testing how patients will respond to various drugs could pave the way for more personalized treatment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.